CoChat

Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Antidepressant drugs (ADs) have been shown to activate BDNF (brain-derived neurotrophic factor) receptor TrkB in the rodent brain but the mechanism underlying this phenomenon remains unclear. ADs act as monoamine reuptake inhibitors and after prolonged treatments regulate brain bdnf mRNA levels indicating that monoamine-BDNF signaling regulate AD-induced TrkB activation in vivo. However, recent findings demonstrate that Trk receptors can be transactivated independently of their neurotrophin ligands. METHODOLOGY: In this study we examined the role of BDNF, TrkB kinase activity and monoamine reuptake in the AD-induced TrkB activation in vivo and in vitro by employing several transgenic mouse models, cultured neurons and TrkB-expressing cell lines. PRINCIPAL FINDINGS: Using a chemical-genetic TrkB(F616A) mutant and TrkB overexpressing mice, we demonstrate that ADs specifically activate both the maturely and immaturely glycosylated forms of TrkB receptors in the brain in a TrkB kinase dependent manner. However, the tricyclic AD imipramine readily induced the phosphorylation of TrkB receptors in conditional bdnf⁻/⁻ knock-out mice (132.4±8.5% of control; P = 0.01), indicating that BDNF is not required for the TrkB activation. Moreover, using serotonin transporter (SERT) deficient mice and chemical lesions of monoaminergic neurons we show that neither a functional SERT nor monoamines are required for the TrkB phosphorylation response induced by the serotonin selective reuptake inhibitors fluoxetine or citalopram, or norepinephrine selective reuptake inhibitor reboxetine. However, neither ADs nor monoamine transmitters activated TrkB in cultured neurons or cell lines expressing TrkB receptors, arguing that ADs do not directly bind to TrkB. CONCLUSIONS: The present findings suggest that ADs transactivate brain TrkB receptors independently of BDNF and monoamine reuptake blockade and emphasize the need of an intact tissue context for the ability of ADs to induce TrkB activity in brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0020567

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Imipramine specifically activates TrkB receptors in the mouse brain. A) The ability of imipramine (30 mg/kg, i.p., 30 min; n = 6/group) to induce rapid TrkB phosphorylation in the hippocampus and medial prefrontal cortex of TrkBF616A mutant mice is abolished with 1NaPP1 pretreatment (25 µM for 1-week in drinking water+83 ng/g co-injection with imipramine). B) A representative blot showing TrkB kinase dependent action of imipramine-induced phosphorylation of TrkB (Y816) and the ∼105 kDa protein. C) A representative blot showing imipramine-induced TrkB phosphorylation in flag-precipitated pool of protein from the brains of mice over-expressing flag-tagged catalytic TrkB receptors. Data is presented as percentage of control/saline ± standard error of mean (SEM). *<0.05, **<0.01; two-way ANOVA with Newmann-Keuls post hoc test.
Figure 1 Imipramine specifically activates TrkB receptors in the mouse brain. A) The ability of imipramine (30 mg/kg, i.p., 30 min; n = 6/group) to induce rapid TrkB phosphorylation in the hippocampus and medial prefrontal cortex of TrkBF616A mutant mice is abolished with 1NaPP1 pretreatment (25 µM for 1-week in drinking water+83 ng/g co-injection with imipramine). B) A representative blot showing TrkB kinase dependent action of imipramine-induced phosphorylation of TrkB (Y816) and the ∼105 kDa protein. C) A representative blot showing imipramine-induced TrkB phosphorylation in flag-precipitated pool of protein from the brains of mice over-expressing flag-tagged catalytic TrkB receptors. Data is presented as percentage of control/saline ± standard error of mean (SEM). *<0.05, **<0.01; two-way ANOVA with Newmann-Keuls post hoc test.CC BY · PubMed Central
Figure 2 Antidepressant drugs activate the immaturely glycosylated form of TrkB. A) Acute imipramine treatment induces the phosphorylation (Y816) of full-length and low-molecular weight (LMW; ∼105 kDa) TrkB receptors in mouse brain. n = 6/group. B) Antidepressant-induced ∼105 kDa protein is sensitive to Endo-H digestion. A representative blot of triplicate data. C) Total TrkB, phosphorylated TrkB (Y816) and phosphorylated ∼105 kDa protein levels are increased in the brains of mice over-expressing catalytic TrkB receptors. n = 5/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05, ***0.005; unpaired two-tailed t-test.
Figure 2 Antidepressant drugs activate the immaturely glycosylated form of TrkB. A) Acute imipramine treatment induces the phosphorylation (Y816) of full-length and low-molecular weight (LMW; ∼105 kDa) TrkB receptors in mouse brain. n = 6/group. B) Antidepressant-induced ∼105 kDa protein is sensitive to Endo-H digestion. A representative blot of triplicate data. C) Total TrkB, phosphorylated TrkB (Y816) and phosphorylated ∼105 kDa protein levels are increased in the brains of mice over-expressing catalytic TrkB receptors. n = 5/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05, ***0.005; unpaired two-tailed t-test.CC BY · PubMed Central
Figure 3 Role of BDNF in antidepressant-induced rapid TrkB activation in brain. Imipramine (30 mg/kg, 30 min, i.p.) readily increases the phosphorylation of TrkB receptors (Y816) in forebrain specific BDNF−/− knock-out mice (BDNF2L/2LCk-cre) n = 4/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05; unpaired two-tailed t-test.
Figure 3 Role of BDNF in antidepressant-induced rapid TrkB activation in brain. Imipramine (30 mg/kg, 30 min, i.p.) readily increases the phosphorylation of TrkB receptors (Y816) in forebrain specific BDNF−/− knock-out mice (BDNF2L/2LCk-cre) n = 4/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05; unpaired two-tailed t-test.CC BY · PubMed Central
Figure 4 Antidepressant drugs amitriptyline and imipramine do not regulate TrkB phosphorylation in primary neurons. A) Whereas BDNF (20 ng/ml; 15 min) robustly increases the phosphorylation of TrkB (Y816) in E18 rat cortical and hippocampal neurons (14 DIV), amitriptyline (left & middle; 0.5 µM, 5 µM; 15 min) and imipramine (0.5 µM, 5 µM; 50 µM; 15 min) produces no change on TrkB phosphorylation. Representative blot of triplicate data. B) Imipramine pre-treatment (4, 12, 40 µM; 15 min) did not facilitate BDNF-induced (5 ng/ml; 15 min) TrkB phosphorylation in E18 rat cortical neurons as measured with phospho-TrkB ELISA. n = 4/group. C) Imipramine pre-treatment (4, 12, 40 µM; 15 min) did not regulate TrkB phosphorylation in its own or in combination with depolarization stimuli (50 mM KCl; 15 min) as measured with phospho-TrkB ELISA. n = 4/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05; one-way ANOVA with Newmann-Keuls post hoc test.
Figure 4 Antidepressant drugs amitriptyline and imipramine do not regulate TrkB phosphorylation in primary neurons. A) Whereas BDNF (20 ng/ml; 15 min) robustly increases the phosphorylation of TrkB (Y816) in E18 rat cortical and hippocampal neurons (14 DIV), amitriptyline (left & middle; 0.5 µM, 5 µM; 15 min) and imipramine (0.5 µM, 5 µM; 50 µM; 15 min) produces no change on TrkB phosphorylation. Representative blot of triplicate data. B) Imipramine pre-treatment (4, 12, 40 µM; 15 min) did not facilitate BDNF-induced (5 ng/ml; 15 min) TrkB phosphorylation in E18 rat cortical neurons as measured with phospho-TrkB ELISA. n = 4/group. C) Imipramine pre-treatment (4, 12, 40 µM; 15 min) did not regulate TrkB phosphorylation in its own or in combination with depolarization stimuli (50 mM KCl; 15 min) as measured with phospho-TrkB ELISA. n = 4/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05; one-way ANOVA with Newmann-Keuls post hoc test.CC BY · PubMed Central
Figure 5 Monoamines and monoamine reuptake in TrkB activation in vitro and in vivo. A) Serotonin selective reuptake inhibitor fluoxetine produced essentially similar changes on hippocampal TrkB phosphorylation in the brains of wild-type and serotonin transporter KO mice, sert −/−. n = 3–5/group. B) Whereas the ability of serotonergic antidepressant citalopram (20 mg/kg, i.p., 60 min) and norepinephrinergic antidepressant reboxetine (20 mg/kg, i.p., 30 min) to induce full-length TrkB receptor phosphorylation (Y816) in mice depleted of serotonin (with pCPA) or norepinephrine (with DSP-4) are reduced, ∼105 kDa protein is heavily phosphorylated by both drugs in the hippocampi of these mice. Representative blots. n = 6–7/group. C) Norepinephrine (NE; 10 nM-10 µM; 15 min) and serotonin (5-HT; 10 nM-10 µM; 15 min) produced no changes on TrkB phosphorylation in BDNF-responsive E18 rat cortical neurons (15DIV) as measured with phospho-TrkB ELISA. n = 4/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05; two-way ANOVA with Newmann-Keuls post hoc test.
Figure 5 Monoamines and monoamine reuptake in TrkB activation in vitro and in vivo. A) Serotonin selective reuptake inhibitor fluoxetine produced essentially similar changes on hippocampal TrkB phosphorylation in the brains of wild-type and serotonin transporter KO mice, sert −/−. n = 3–5/group. B) Whereas the ability of serotonergic antidepressant citalopram (20 mg/kg, i.p., 60 min) and norepinephrinergic antidepressant reboxetine (20 mg/kg, i.p., 30 min) to induce full-length TrkB receptor phosphorylation (Y816) in mice depleted of serotonin (with pCPA) or norepinephrine (with DSP-4) are reduced, ∼105 kDa protein is heavily phosphorylated by both drugs in the hippocampi of these mice. Representative blots. n = 6–7/group. C) Norepinephrine (NE; 10 nM-10 µM; 15 min) and serotonin (5-HT; 10 nM-10 µM; 15 min) produced no changes on TrkB phosphorylation in BDNF-responsive E18 rat cortical neurons (15DIV) as measured with phospho-TrkB ELISA. n = 4/group. Data is presented as percentage of control ± standard error of mean (SEM). *<0.05; two-way ANOVA with Newmann-Keuls post hoc test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 124

Metadata

Authors
Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E.
Affiliations
  • University of Helsinki (FI)
  • University of Würzburg (DE)
  • Tufts University (US)
Corresponding author
Rantamäki, Tomi
Venue
PLoS ONE
Published
2011-06-07
Volume
6
Issue
6
Pages
e20567
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2019787596
Cited by
124
References
49
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 11 · 2021: 14 · 2020: 7 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 11 · 2012: 11
FWCI
7.50
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
Funders
  • Helsingin Yliopisto
  • Deutsche Forschungsgemeinschaft
  • Suomen Kulttuurirahasto
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
antidepressants, TrkB receptor, brain-derived neurotrophic factor, receptor transactivation, monoamine reuptake inhibitors, serotonin transporter, imipramine, fluoxetine, citalopram, reboxetine, monoamine signaling, antidepressant mechanism
MeSH terms
Aging, Amitriptyline, Animals, Antidepressive Agents, Brain, Glycosylation, Imipramine, Mice, Inbred C57BL, Phosphorylation, Transcriptional Activation, Brain-Derived Neurotrophic Factor, Receptor, trkB, Serotonin Plasma Membrane Transport Proteins, Vesicular Monoamine Transport Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade. https://app.cochat.ai/papers/10.1371/journal.pone.0020567
The paper
Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011). Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade. PLoS ONE. https://doi.org/10.1371/journal.pone.0020567

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.